Scancell Share Discussion Threads

[the real lozan] 30/8/2018 08:44

Dr D -
Oh HE will turn-up alright, and so will HIS EGO
And try to CONtrol proceedings
Then CLAIM on forums, that the BoD, including Lindy herself,not only agreed with HIM, but 'thanked HIM' for explaining / putting her straight on - the science.
.
Heading towards September now...our favourite time of year here in S W France... long days of sitting-out, relaxing in the more tolerable sunshine, knowing the 'projects' have been done.
And, not forgetting those due 'final results' will give an insight to REALITY, for those able to gather 'insight'
Even if they are 'delayed' for any reason.
No 'reason' they should be, of course

[tosh123] 30/8/2018 07:50

Morning all,
thank goodness for Ivy over on the cartoon comic site, he's perfectly summed up the village idiot in a few posts, so much so that our caped crusader resorted to " my portfolio is bigger than yours " , which made me laugh out loud, what a d1ck !

If ever there was a more despicable urchin to walk this planet, i have not heard of him.
His ego knows no bounds, yet he gets everything wrong, it truly is a marvel that one man can get so much wrong, so much of the time... His mistakes are endless...

Anyway, im happy to leave the idiot nursing his losses, whilst the rest of the planet carry on making money.

[gazza] 29/8/2018 23:13

Inan, here's a prediction:In H1 2020, the share price will be closer to 12p than £6.

[gazza] 29/8/2018 23:11

"must admit i have never sat and admired natural gas"Surely you must have? There's plenty of it emitting from your, er, person.

[inanaco] 29/8/2018 21:03

Loz

You have done well .... you can admire the logs "i moved them" ....

must admit i have never sat and admired natural gas ... should we consider it ? some sort of new age art form ?

[inanaco] 29/8/2018 21:00

Gazza we have a prediction from you .... all is good mate 12p ... 2020 (before results of trials )

[gazza] 29/8/2018 20:44

Wigwam, yes, many potential triggers. I guess I just hope for the Best but plan for the worst.

[wigwammer] 29/8/2018 20:38

I'm sure the years you've spent here - day in day out - have been hugely worthwhile :)

[the real lozan] 29/8/2018 20:03

I don't deny, that in recent months, I have spent time on various 'projects' =
Researched, tested and purchased our chosen new SUV
Repairing one of our roofs - replacing timbers and canal tiles where required, flashing and pointing.
Taken 3 deliveries of 'winter fuel oak logs' - in and stacked
And many more day to day tasks that one might say, allow one to = Get a life
.
I also freely admit, that said 'projects' involved expending a certain amount of 'effort' on my/our part.
A similar 'amount of effort' one could say, to the apparent 'amount of effort' spent day in day out, by the 'Dead money specialists' and 'Underwater NAIVE trHYPERS and swallowers.' on here in order to CONvince others to join their FAILED SCAM, and soothe their 'battered EGOs'
.
The BIG difference IS = I have something to show for my/our = expending that certain amount of 'effort'.

[wigwammer] 29/8/2018 19:34

Gaz - it is kind of you to offer help and I'm sure he needed it - but I think we all know what he meant. Regarding timelines - even the IND may be a trigger to a significant rerating, but beyond that both TCR and Grand Challenge news flow likely before results. I would also expect a significant rerating prior to read out as the market increasingly focuses on what a positive result would mean (esp for moditope). Risks - ongoing delay of IND, losing out on GC, Biontech lack of interest, trial failure - individuals need to make up their own mind about plausibility of each of those. To me, represents excellent risk/reward but to each their own.

[inanaco] 29/8/2018 19:07

so the question i ask

why are you both holding ???????????????????

[inanaco] 29/8/2018 19:06

So we have a prediction ...........

Tosh predicted no movement until 2020 = 10p or lower

Gazza has now predicted no movement until 2020 = 12p stagnant

lozan has water damage ... so will not comment

[gazza] 29/8/2018 19:03

I think some people need help with English. The last time Lozan suggested we might be in for a lull I had to agree. I still agree. Lull does NOT mean going down it means a period of inactivity. The share price and volume have stagnated. As I said last time, this is unlikely to change until trials have started AND some positive results have been reported. Probably 2020 or late 2019 best case. IMO.

[inanaco] 29/8/2018 18:52

dementia never improves with age ...

[wigwammer] 29/8/2018 18:48

Well his last post was a big improvement. All the joyless irrelevance one has come to expect but without the unnecessary word count :)

[the real lozan] 29/8/2018 18:35

Flounder ???

[wigwammer] 29/8/2018 18:27

Actually I'm a little amused that this "lull" as you describe it is even worth mentioning. Perhaps victories in your life have been few and far between :) The shares are at 12p, around where they were at the placing in April. For there to have been a "lull" I can only assume there was a rise first, which WE ALL KNOW you never predicted. Please enjoy your logs :)

[inanaco] 29/8/2018 17:51

Fair enough which actually makes the value higher as its very specific, if they have ruled out the T cell side of the platform in other words they could have paid more to fully access the potential unless they see no point in that as the NK cell already has the binding onto the bispecific antibody thus only one arm needs to change to move to another cancer target

[bermudashorts] 29/8/2018 17:17

Inan,

Re. your 17347, it is only for NK cell products. You've taken a paragraph out of context which is simply describing Affimed's ROCK platform - Genentech are licensing NK cell products generated by that platform. This is the previous paragraph from the announcement:-

"Heidelberg, Germany, August 27, 2018 - Affimed N.V. (Nasdaq:AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies that harness the power of innate and adaptive immunity (NK and T cells), today announced that it has entered into a strategic collaboration agreement with Genentech, a member of the Roche Group, to develop and commercialize novel NK cell engager-based immunotherapeutics to treat multiple cancers."

Have a look at slide no. 5 from their corporate presentation

[wigwammer] 29/8/2018 16:34

Jeez.. another bag of sh1te written on this board this afternoon. For those interested in Scancell - genentech did a deal in an area adjacent to Scancell, very high upfront payment relative to market value, the 18 year wait evidently suggesting little about the quality of science or current commercial interest in the assets.